Board of the Pension Protection Fund Purchases New Stake in DaVita Inc. (NYSE:DVA)

Board of the Pension Protection Fund bought a new stake in shares of DaVita Inc. (NYSE:DVAFree Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 4,900 shares of the company’s stock, valued at approximately $733,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Transcendent Capital Group LLC bought a new stake in shares of DaVita during the 3rd quarter valued at about $25,000. Blue Trust Inc. boosted its stake in DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after acquiring an additional 119 shares during the period. Quarry LP acquired a new position in DaVita in the third quarter valued at approximately $60,000. Versant Capital Management Inc raised its position in shares of DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Point72 Hong Kong Ltd bought a new stake in shares of DaVita in the 2nd quarter worth approximately $68,000. 90.12% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently commented on DVA. Barclays upped their price objective on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial upped their price target on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $161.80.

Get Our Latest Report on DVA

DaVita Trading Up 3.1 %

NYSE:DVA opened at $161.92 on Wednesday. The stock has a market cap of $13.28 billion, a price-to-earnings ratio of 17.47, a PEG ratio of 0.86 and a beta of 0.92. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. DaVita Inc. has a 1 year low of $103.40 and a 1 year high of $169.51. The business has a fifty day moving average of $155.89 and a 200-day moving average of $152.20.

DaVita (NYSE:DVAGet Free Report) last released its earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). The company had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the business posted $2.85 EPS. Equities analysts predict that DaVita Inc. will post 9.71 earnings per share for the current year.

DaVita Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Read More

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVAFree Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.